Medical care decreases after RFK Jr.’s appointment, but analysts warn about excessive reaction
Medical care and vaccine actions experienced a fall on Friday after President -elect Donald Trump announced his Robert F. Kennedy Jr.’s team to direct the Department of Health and Human Services of the United States (HHS). However, some experts believe that the market response can be an exaggerated reaction, emphasizing the uncertainty surrounding the potential impact of RFK Jr.’s appointment.
In a note for customers on Friday, JP Morgan analyst Chris Schott, highlighted the challenges to evaluate the long -term effects of this decision. “It is difficult to measure the exact implications until more details arise regarding the specific medical care policies and priorities of the incoming administration,” Schott said.
RFK Jr., known for its strong opposition to the drug approval process, will have the power to appoint leaders for critical health agencies within the HHS, including the FDA and the CDC.
Although Schott acknowledged that the recession of the health sector is understandable, given the previous public opinions of RFK Jr. on the industry, he also emphasized that the real impact of this appointment remains uncertain. “We are not surprised by the pressure of the sector, considering the past positions of RFK Jr. in medical care, but much depends on real policies,” Schott added.
As with other elements of Trump’s policy perspective, it is not clear how much of rhetoric will translate into formal policy decisions.
(Tagstotranslate) US Stock Market financial
Source link